Title: Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2
PDB DOI: https://doi.org/10.2210/pdb6g9j/pdb
Primary publication DOI: https://doi.org/10.1021/acs.jmedchem.8b00421
Entry authors: O'Reilly, M.
Initial deposition on: 10 April 2018
Initial release on: 30 May 2018
Latest revision on: 20 November 2024
Structure coordinates (PDBx/mmCIF)
X-ray diffraction data (PDBx/mmCIF)